SCHEMBL19081456

SCHEMBL19081456

c1ccc2c(-c3c4ccccc4c(-c4c5oc6ccc7ccccc7c6c5cc5oc6ccccc6c45)c4ccccc34)cccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
AHR P35869 4/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ALOX5 P09917 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP1A1 P04798 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
PAX8 Q06710 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081650 0.95 TDP1 (0.40) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL19081539 0.92 TDP1 (0.37) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL17945503 0.91 ALOX5 (0.39) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL19081556 0.91 TDP1 (0.36) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL17945165 0.86 ALOX5 (0.42) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL19081653 0.85 ALOX5 (0.41) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL19081451 0.85 TDP1 (0.41) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL19081702 0.84 TDP1 (0.39) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL17932127 0.82 ALOX5 (0.41) TDP1L3MBTL1AHRMAPTMEN1
SCHEMBL17943998 0.82 L3MBTL1 (0.41) TDP1L3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885AHR 2453/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885AHR 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.